Netscientific PLC
F:NTK1

Watchlist Manager
Netscientific PLC Logo
Netscientific PLC
F:NTK1
Watchlist
Price: 0.565 EUR
Market Cap: €13.5m

Netscientific PLC
Investor Relations

NetScientific Plc is a healthcare medical technology company, which engages in sourcing, funding, and commercializing technologies that improve the health and well-being of people with chronic diseases. Its portfolio consists of a combination of direct investments and capital under advisory. The company has developed a customized investment and realization strategy for its portfolio companies through management, incubation, advisory services and fund-raising support. The company facilitates the companies it works with, to access the type of funding, management support and resources specific to their sector, stage of development and available opportunities. The firm's subsidiaries include EMV Capital Limited, Glycotest, Inc. and ProAxsis Limited, among others.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Dr. Ilian Petkov Iliev Ph.D.
CEO & Executive Director
No Bio Available
Mr. Edward Benjamin Peter Hooper
General Counsel & Executive Director
No Bio Available
Mr. Stephen Daniel Crowe
CFO & Secretary
No Bio Available
Ms. Vyara Stoycheva
Investment Manager
No Bio Available
Mr. Nick Salisbury
Head of Capital Raising & Co-Investment
No Bio Available
Mr. Ian Cooke
Venture Partner of Sustainability
No Bio Available
Dr. Frank K. Bedu-Addo Ph.D.
Chief Executive Officer of PDS Biotechnology
No Bio Available
Ms. Hannah Jarvis
Financial Controller
No Bio Available
Mr. Kevin John Dean
Venture Partner
No Bio Available
Mr. Christopher Niehaus
Adviser
No Bio Available

Contacts

Address
London
PO Box 76075
Contacts
+442035141800.0
netscientific.net
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett